Navigation Links
Sonic Foundry completes $11.25M stock offer

Madison, Wis. - Sonic Foundry, Inc. has closed a public offering of three million shares of common stock in which it raised $11.25 million for general corporate purposes.

The company announced on Dec. 21 the offering of common stock at $3.75 per share, marketed to institutional investors following a shelf-registration statement previously filed......

Full article >>>
'"/>

Source:wistechnology.com By WTN Media 12/27/06


Page: 1

Related biology technology :

1. Sonic Foundry reports GAAP loss as Q2 revenues rise
2. Sonic Foundry upgrades Mediasite for podcasts
3. Sonic Foundry reports net loss, higher revenue
4. New Sonic Foundry search engine finds words, phrases in video presentations
5. Sonic Foundry sets $3.75 stock price
6. Sonic Foundry explores capital options
7. Sonic Foundry reports first cash-positive quarter
8. Visions: Rimas Buinevicius, CEO of Sonic Foundry
9. Sonic closer to turning profit corner
10. Sonic Foundry offers Mediasite to military families
11. Sonic Foundrys Mediasite moves to podcasts
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/18/2020)... MILWAUKEE (PRWEB) , ... July 16, 2020 , ... “We ... at Third Wave Bioactives. “It’s the only technology of its kind on the market ... flavor of onions with the protective capacity of traditional cultured ingredients, creating a natural ...
(Date:7/18/2020)... ... July 17, 2020 , ... ... firm for the life sciences and food industries, is pleased to announce that ... Clinical Research – Business Development. , Charles is an accomplished and results-driven sales ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... Technology (MIT) has expanded the company’s exclusive license to include clinical applications ... point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast ...
(Date:7/10/2020)... Mass. (PRWEB) , ... July 09, 2020 , ... ... approaches to cell therapy, today announced the hiring of Allen R. Nissenson, M.D., ... team and oversee the clinical development of Sentien’s lead product, SBI-101. Dr. ...
Breaking Biology Technology:
(Date:8/26/2020)... ... August 25, 2020 , ... ... company developing novel pharmaceuticals targeting mitochondria, in partnership with Essex Bio-Technology, a ... its pivotal U.S. Phase 3 VISTA-2 study of SkQ1 ophthalmic solution in ...
(Date:8/21/2020)... , ... August 18, 2020 , ... ... cell therapy, today announced that the U.S. Food and Drug Administration (FDA) has ... lead asset, SBI-101, for the treatment of severe COVID-19. Approval of this IND ...
(Date:8/12/2020)... ... August 11, 2020 , ... Both Roche, ... have entered into license agreements with Housey Pharma’s HMI subsidiary to gain access ... J&J have annual Research and Development spending in excess of US $10 billion. ...
Breaking Biology News(10 mins):